About Guardant Health
Guardant Health (NASDAQ:GH) is a pioneering company focused on conquering cancer with its ground-breaking blood tests, vast data sets, and analytics. Their operations span from developing and commercializing oncology diagnostic products and services, which enable more accurate therapeutics, to providing comprehensive genomic profiling assays that support clinical development, prevention, and early detection of cancer. Guardant Health's significant projects include the Guardant360 and GuardantOMNI tests for advanced stage cancer patients and the LUNAR assay for research use and early cancer detection. With a mission to improve patient outcomes and increase the efficiency of cancer care, Guardant Health is at the forefront of driving forward precision oncology. The company is traded on the NASDAQ stock market under the ticker code (NASDAQ:GH), reflecting its commitment to innovation and leadership in the healthcare sector.
Snapshot
Operations
Products and/or services of Guardant Health
- Guardant360, a comprehensive liquid biopsy for advanced cancer patients.
- GuardantOMNI, a genome-scale sequencing tool for biopharmaceutical companies.
- LUNAR-1, for detecting residual disease and recurrence in cancer patients.
- LUNAR-2, a blood test aimed at early detection of cancer.
- GuardantINFINITY, for deep longitudinal tumor profiling to support drug development.
- Digital Spatial Profiling, a technology enabling highly multiplexed spatial profiling of protein and RNA in tissues.
Guardant Health executive team
- Dr. Helmy Eltoukhy Ph.D.Co-Founder, Co-CEO & Chairman
- Dr. AmirAli Talasaz Ph.D.Co-CEO & Director
- Mr. Michael BellChief Financial Officer
- Ms. Darya ChudovaChief Technology Officer
- Mr. John G. Saia J.D.Chief Legal Officer & Corporate Secretary
- Ms. Terilyn Juarez MonroeChief People Officer
- Mr. Andy AmentSenior Vice President of Operations
- Mr. Kumud KaliaChief Information Officer
- Zarak KhurshidVice President of Investor Relations
- Ms. Gulshan Shaver J.D.Senior VP of Legal Affairs & Chief Compliance Officer